Effects of disease-modifying drugs on serum neurofilament light chain, chitinase-3-like-1 protein levels, and selected plasmacytoid dendritic cell biomarkers in relapsing-remitting multiple sclerosis
The serum NFL and CHI3L1 need to be validated as drug response biomarkers in RRMS patients, evaluating the DMDs' effect on immunocellular level by studying migratory and tolerogenic functions of pDCs.
Authors
- E.-S. A. M. Badawy
- Tarek Ali Rageh
- Basant Rashad
- Dalia T. Kamal
- Sohair K. Sayed
Institutions
- Assiut University (EG)
Publication Details
- Journal
- African Journal of Laboratory Medicine
- Published
- 2026-01-20
- DOI
- https://doi.org/10.4102/ajlm.v15i1.2901
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Assiut University
- Faculty of Medicine, Assiut University